This study identifies PBLD as a positive regulator of STING‐induced type I interferon activation and delineated the molecular network underlying PBLD‐mediated antiviral immunity and autoimmune pathogenesis, highlighting its potential as a therapeutic target for both antiviral infections and autoimmune diseases. This evidence concerns the gene PBLD and autoimmune disease.